reduce insulin dose when starting glp-1 receptor agonist Drugs and Type 1 Diabetes: Less Insulin, Better Time in Range — What the Evidence GLP-1 Drug Savings: A Complete

In a study on Medicaid recipients, Jerrell found that black children with obesity had more diagnosed medical conditions but received less health care than non-black children [213]

Article 47

In addition to regulating apoptosis, GLP-1RAs also fine-tune mitochondrial quality control via mitophagy

For instance, in January 2025, the FDA approved semaglutide (Ozempic) as a medication to reduce the risk of kidney failure, kidney disease progression, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease (CKD)

Potential miRNA-based interventions include restoring or suppressing miRNA activity using synthetic mimics or inhibitors (anti-miRs) (101, 102)